✦ LIBER ✦

PCN3 ECONOMIC IMPACT OF SECOND- ANDTHIRD-LINE ERLOTINIB TREATMENT OF NON SMALL-CELL LUNG CANCER:A FRENCH OBSERVATIONAL STUDY

✍ Scribed by C Chouaid; A Vergnenegre; A Moser; C Coudray-Omnes

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN25 COST-EFFECTIVENESS ANALYSIS OF ERL

✍ Kim, YG; Lee, EK 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

PCN90 Cost-Effectiveness Analysis of Erl

✍ Nguyen, T.T.T.; Yagudina, R.; Kulikov, A. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PCN81 COST-EFFECTIVENESS ANALYSIS OF THR

✍ I Borget; J Cadranel; A Mauguen; B Coudert; E Dansin; S Friard; C Daniel; E Quoi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PCN36 ECONOMIC EVALUATION OF ERLOTINIB,

✍ S Capri; A Morabito; G Carillio; F Grossi; R Longo; G Cerea; F Rossetti 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PCN52 ECONOMIC ANALYSIS OF ERLOTINIB, DO

✍ F Negreiro; C Pereira; H Pereira; C Silva 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

An economic analysis of erlotinib, docet

✍ A. Araújo; B. Parente; R. Sotto-Mayor; E. Teixeira; T. Almodôvar; F. Barata; H. 📂 Article 📅 2008 🏛 Elsevier ⚖ 288 KB